The COVID-19 Market: Keeping Up With The Changing Landscape

Some products are still going strong, while others that once generated blockbuster revenues have faded away, as companies develop next-generation antivirals and vaccines.

In their Q2 earnings, several companies provided updates on their COVID-19 drugs, vaccines and development programs • Source: Shutterstock

More from COVID-19

More from Scrip